Burwell Expects To Update Congress On Part B Drug Demo Soon

HHS Secretary Sylvia Burwell told House Energy & Commerce members that CMS soon will update Congress on the Part B drug demonstration plan that the agency accidentally told contractors about this month. The way Medicare currently pays physicians to administer drugs, usually biologics, has been criticized as encouraging providers to use expensive products because a portion of provider reimbursement is based on the percentage of drug prices. The notice that CMS inadvertently sent Medicare Administrative Contractors on Feb. 5 states...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.